Centogene rises after launching COVID-19 detection kit

Crown LiquidationCo NV in liquidatie

21/04/2020 16:49

** U.S.-listed shares of diagnostic and pharma company
 CNTG.O  rise 9% to $17.44
    ** CNTG launches swab sampling kit, CentoSwab, for detection
of SARS-CoV-2, which causes COVID-19 disease  urn:newsml:reuters.com:*:nGNXbq81rx
    ** Kit consists of sterile package containing a swab and
collection tube
    ** Including session's gain, stock up ~73% YTD

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))